Sunday, November 8, 2026

USD/CNH Went Down By Over 3% In The Last 21 Sessions

ViaNews Editorial Team

February 22, 2023

USD/CNH Went Down By Over 3% In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 3.73% for the last 21 sessions. At 16:11 EST on Wednesday, 22 February, USD/CNH (USDCNH) is $6.91.

USD/CNH's yearly highs and lows, it's 0.295% up from its 52-week low and 0.029% down from its 52-week high.

News about

  • Eur/usd aims to recapture 1.0700 as risk appetite recovers, fed minutes in focus. According to FXStreet on Monday, 20 February, "The EUR/USD pair has attempted a recovery after dropping to near 1.0673 in the early European session. "
  • Eur/usd: hawkish ECB talks, upbeat EU data tease bulls near 1.0700, pmis in focus. According to FXStreet on Monday, 20 February, "Against this backdrop, Wall Street was closed and US Treasury yields eased, which in turn weighed on the US Dollar Index (DXY) and allowed the EUR/USD to remain firmer, defending Friday's rebound from the six-week low.", "Moving on, the return of full markets may highlight the geopolitical fears surrounding the US-China tussles over Taiwan and balloon shooting, not to forget the North Korean missile firing, to weigh on the sentiment and the EUR/USD prices."
  • Eur/usd to fall back towards support from the 200-dma at around 1.0330 – MUFG. According to FXStreet on Monday, 20 February, "Therefore, economists at MUFG Bank expect the EUR/USD pair to challenge the 200-Day Moving Average (DMA) at around 1.0330.", "We are expecting the EUR/USD pair to fall back towards support from the 200-DMA that comes in at around 1.0330."
  • Eur/usd drops to near 1.0660 as risk-off impulse solidifies ahead of eurozone ZEW survey. According to FXStreet on Tuesday, 21 February, "The EUR/USD pair has slipped to near 1.0660 in the Asian session as the risk appetite of the market participants has trimmed ahead of the global PMI figures. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com